Press releases
NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan
Oct 05, 2026
https://ir.neogenomics.com/news-events/press-releases/detail/339/neogenomics-announces-executive-leadership-and-board-of-directors-succession-plan
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Sep 01, 2026
https://ir.neogenomics.com/news-events/press-releases/detail/338/neogenomics-to-participate-in-the-morgan-stanley-24th-annual-global-healthcare-conference
NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring
Aug 26, 2026
https://ir.neogenomics.com/news-events/press-releases/detail/337/neogenomics-receives-medicare-coverage-for-radar-st-for-immunotherapy-treatment-response-monitoring
NeoGenomics Reports Second Quarter 2026 Results
Jul 28, 2026
https://ir.neogenomics.com/news-events/press-releases/detail/336/neogenomics-reports-second-quarter-2026-results
NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS
Jul 20, 2026
https://ir.neogenomics.com/news-events/press-releases/detail/335/neogenomics-announces-settlement-of-voluntary-disclosure-to-oig-hhs
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
Jul 09, 2026
https://ir.neogenomics.com/news-events/press-releases/detail/334/neogenomics-launches-fda-approved-pten-ihc-companion-diagnostic-for-prostate-cancer
CTA style
Default